Amyloidosis is a disease of deposits classified into systemic and localized1. The head and neck involvement is rare, and the larynx is the most affected site2–3. Ear amyloidosis is a rare occurence4. The definitive diagnosis is histopathological1. The disease is more frequent between 50-70 years of age, and it predominates in men (3:1). Its etiology is unknown1.

Because of the severity of the systemic form of the disease and its association with plasmocytoma and multiple myeloma, it is important to distinguish these manifestations5.

We present here a case of a 42-year-old patient with ear amyloidosis.

M.A.S., 42 years old, female, referred to us with recurrent otalgia and hearing loss secondary to amyloidosis, diagnosed 21 years ago, she reported onset of earache and fullness in the ear for about 4 days before coming to the clinic, besides floating hearing loss. She was using amitriptyline, Arcox® and codeine. Upon the exam, there were hyperemia and edema of the outer ear and pinna (Figure 1).

Figure 1.

Amyloidosis lesion on the ear pinna.

(0.05MB).

Otoscopy was difficult, because of edema in the canal, showing a normal ear drum.

The pathology exam of the pinna skin biopsy showed homogeneous eosinophilic material in the dermis and a positive dye for amyloidosis, with methyl violet.

We ordered lab exams: ESR, CBC, renal and liver function tests, beta 2 microglo-bulin, protein electrophoresis and abdominal subcutaneous tissue biopsy. They came back all normal. The pathology report from the subcutaneous tissue read: Normal fibrous-fat tissue and a search for amyloidosis with the Congo red dye with negative birefringent polarized light.

Vocal and tonal audiometry showed moderate hearing loss and tympanometric type A curve, bilaterally, with preserved stapes reflexes.

The external auditory canals and pinna were filled with topical steroid (0.5% clobetasone cream), once a week, for 4 weeks, evolving with symptom improvements.

Today, the patient is being observed.

Amyloidosis is a rare disease, with deposits of protein fibrils. Such protein build up in the tissues may compromise the function of organs, such as the heart1. In 20%, there is multiple myeloma associated -plasmacytic neoplasia, medullary infiltration by plasmacytes, associated with the serum M protein (monoclonal immunoglobulin), and organic injury5.

In head and neck amyloidosis, systemic involvement must be ruled out by laboratory tests, such as protein electrophoresis, renal function test, electrocardiogram and abdominal ultrasound2. The study of monoclonal production of immunoglobulins is important4; the systemic form of the disease happens when there is monoclonal protein in the serum or urine and organ involvement, such as albuminuria (amyloidosis corresponds to 10% of the non-diabetic nephrotic syndromes in adults), heart disease, hepatomegaly, neuropathy and bone marrow infiltrated by at least 10% of plasmocytes4,5.

In this paper, we report partial and temporary stenosis of the external auditory canal, affecting the pinna - a rare manifestation of amyloidosis. In the few reports present in the literature, fullness of the ear and hearing loss are constant findings, which did not happen with pain - which was not reported by other papers.

In most cases, amyloidosis is systemic and follows multiple myeloma5. The treatment proposed for amyloidosis in the literature is based on lesion exeresis4.

There are but a few studies on amyloidosis. Among the localized forms, the ear form is rare. The definition of clinical and laboratory characteristics is important for its diagnosis. It is important to investigate multiple myeloma in the systemic form of the disease.